Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 10,091 | 12,243 | 10,995 | 14,229 |
| Cost of Goods | N/A | 3,285 | 2,457 | 2,414 | 2,823 |
| Gross Profit | N/A | 6,806 | 9,786 | 8,581 | 11,406 |
| Operating Expenses | 13,697 | -33,178 | 16,740 | 16,342 | 16,376 |
| Operating Income | -13,697 | 40,269 | -6,497 | -7,347 | -4,147 |
| Interest Expense | 3,259 | 3,237 | 3,190 | 3,190 | 3,125 |
| Other Income | 213 | -866 | -688 | -1,199 | 642 |
| Pre-tax Income | -16,743 | 36,166 | -10,375 | -11,736 | -6,630 |
| Income Tax | -5,040 | 5,292 | -9,510 | -8,997 | 2,234 |
| Net Income Continuous | -11,703 | 30,874 | -865 | -2,739 | -8,864 |
| Net Income | $-11,703 | $30,874 | $-865 | $-2,739 | $-8,864 |
| EPS Basic Total Ops | -0.20 | 0.57 | -0.02 | -0.07 | -0.24 |
| EPS Basic Continuous Ops | -0.20 | 0.57 | -0.02 | -0.07 | -0.24 |
| EPS Diluted Total Ops | -0.20 | 0.49 | -0.02 | -0.07 | -0.24 |
| EPS Diluted Continuous Ops | -0.20 | 0.44 | -0.02 | -0.07 | -0.24 |
| EBITDA(a) | $-13,375 | $40,788 | $-6,041 | $-6,551 | $-3,521 |